FDA Inspection 1219348 — SRI Krishna Pharmaceuticals Ltd - Unit I
The FDA completed an inspection of SRI Krishna Pharmaceuticals Ltd - Unit I on September 1, 2023 in Hyderabad. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 1, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hyderabad (India)